Journal of Clinical Oncology 临床肿瘤· Steven J. Chmura·· 2026-10-08AI 评分55
NRG-BR002 随机II/III期试验:转移导向消融联合一线系统治疗用于寡转移性乳腺癌
NRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast Cancer
AI 导读
Journal of Clinical Oncology 发表 NRG-BR002 随机II/III期试验,研究转移导向消融联合一线系统性治疗用于寡转移性乳腺癌患者的初步疗效结果。
来源:Journal of Clinical Oncology 临床肿瘤 · ascopubs.org